Researchers have long argued that a heralded spinal treatment sold by the nation?s largest device maker, Medtronic, was no better than an older one and possibly more risky. Now with the company?s help, they have the proof.
Researchers have long argued that a heralded spinal treatment sold by the nation?s largest device maker, Medtronic, was no better than an older one and possibly more risky. Now with the company?s help, they have the proof.